174 related articles for article (PubMed ID: 11420096)
1. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.
Carley DW; Depoortere H; Radulovacki M
Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
[TBL] [Abstract][Full Text] [Related]
3. Serotonin 5-HT3-receptor antagonist GR 38032F suppresses sleep apneas in rats.
Radulovacki M; Trbovic SM; Carley DW
Sleep; 1998 Mar; 21(2):131-6. PubMed ID: 9542796
[TBL] [Abstract][Full Text] [Related]
4. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
5. Serotonin stimulation of 5-HT4 receptors indirectly enhances in vivo dopamine release in the rat striatum.
De Deurwaerdère P; L'hirondel M; Bonhomme N; Lucas G; Cheramy A; Spampinato U
J Neurochem; 1997 Jan; 68(1):195-203. PubMed ID: 8978726
[TBL] [Abstract][Full Text] [Related]
6. Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.
Idres S; Delarue C; Lefebvre H; Vaudry H
Brain Res Mol Brain Res; 1991 Jun; 10(3):251-8. PubMed ID: 1653392
[TBL] [Abstract][Full Text] [Related]
7. Role of peripheral serotonin in the regulation of central sleep apneas in rats.
Carley DW; Radulovacki M
Chest; 1999 May; 115(5):1397-401. PubMed ID: 10334159
[TBL] [Abstract][Full Text] [Related]
8. Use of stereoisomers of zacopride to analyze actions of 5-hydroxytryptamine on enteric neurons.
Wade PR; Mawe GM; Branchek TA; Gershon MD
Am J Physiol; 1991 Jan; 260(1 Pt 1):G80-90. PubMed ID: 1987811
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
10. Role of serotonin3 receptors in the nucleus tractus solitarii on the carotid chemoreflex.
Sévoz C; Callera JC; Machado BH; Hamon M; Laguzzi R
Am J Physiol; 1997 Mar; 272(3 Pt 2):H1250-9. PubMed ID: 9087599
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective effects of (R)- and (S)-zacopride on cognitive performance in a spatial navigation task in rats.
Fontana DJ; Daniels SE; Eglen RM; Wong EH
Neuropharmacology; 1996 Mar; 35(3):321-7. PubMed ID: 8783207
[TBL] [Abstract][Full Text] [Related]
12. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
13. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors.
Squires RF; Saederup E
Neurochem Res; 1999 May; 24(5):659-67. PubMed ID: 10344595
[TBL] [Abstract][Full Text] [Related]
14. Characterisation of the non-5-HT3 high-affinity 'R' binding site for (R)-zacopride in brain and other tissues.
Kidd FJ; Levy JC; Nielsen M; Hamon M; Gozlan H
Eur J Pharmacol; 1993 Sep; 247(1):45-56. PubMed ID: 8258360
[TBL] [Abstract][Full Text] [Related]
15. Mirtazapine, a mixed-profile serotonin agonist/antagonist, suppresses sleep apnea in the rat.
Carley DW; Radulovacki M
Am J Respir Crit Care Med; 1999 Dec; 160(6):1824-9. PubMed ID: 10588592
[TBL] [Abstract][Full Text] [Related]
16. Repeated corticosterone administration increases excitatory effect of 5-HT4 receptor agonist in the rat hippocampus.
Zahorodna A; Tokarski K; Bijak M
Pol J Pharmacol; 2000; 52(2):107-9. PubMed ID: 10949112
[TBL] [Abstract][Full Text] [Related]
17. The effects of selective activation of the 5-HT3 receptor with m-chlorophenylbiguanide on sleep and wakefulness in the rat.
Ponzoni A; Monti JM; Jantos H
Eur J Pharmacol; 1993 Nov; 249(3):259-64. PubMed ID: 8287912
[TBL] [Abstract][Full Text] [Related]
18. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
Contesse V; Hamel C; Lefebvre H; Dumuis A; Vaudry H; Delarue C
Mol Pharmacol; 1996 Mar; 49(3):481-93. PubMed ID: 8643088
[TBL] [Abstract][Full Text] [Related]
19. Central action of 5-HT3 receptor ligands in the regulation of sleep-wakefulness and raphe neuronal activity in the rat.
Adrien J; Tissier MH; Lanfumey L; Haj-Dahmane S; Jolas T; Franc B; Hamon M
Neuropharmacology; 1992 Jun; 31(6):519-29. PubMed ID: 1407392
[TBL] [Abstract][Full Text] [Related]
20. Distribution and characterisation of the [3H](S)-zacopride labelled 5-HT3 receptor in pig forebrain.
Fletcher S; Barnes NM
Brain Res; 1996 Aug; 729(2):281-4. PubMed ID: 8877001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
